Norway· NO-ID_BBCE2FCE-B87E-4E3D-9E19-4E32E91974E0
Amphotericin B liposomal Tillomed
A amphotericin b product containing amphotericine b + liposome, registered in Norway by Tillomed Malta Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Amphotericin b is registered in 11 of 19 countries.
Countries holding a registration under ATC J02AA01 (amphotericin b), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Amphotericin b · ATC J02AA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of amphotericin b costs, country by country.
Normalised to the WHO defined daily dose (35 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Amphotericin b · price per daily dose (35 mg)
USD · FX 28 Sept 2026
- CH Switzerland$109.86
The record
At a glance
FEST (Norway)- Active substance
- Amphotericine B + Liposome
- Manufacturer
- Tillomed Malta Ltd
- Country
- Norway (NO)
- ATC code
- J02AA01
- ATC class
- Amphotericin B
- Defined daily dose
- 35 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_BBCE2FCE-B87E-4E3D-9E19-4E32E91974E0
- no_varenummer37401810 x 50NOK 14052.2
- gtin5350765900509
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
391 interactions on record for amphotericin b.
Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amphotericin b · interactions on record
391 records
- 31 severe
- 114 moderate
- 10 minor
- 236 info
Most severe, free to view
- AmiodaroneC01BD01severe
- DofetilideC01BD04severe
- DronedaroneC01BD07severe
- CidofovirJ05AB12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J02AA01
Amphotericin b, as other registers publish it.
- FinlandAbelcetTeva Pharma B.V.
- PolandAbelcetTeva Pharmaceuticals Polska Sp. z o.o.
- FinlandAbelcet Lipid ComplexParanova Oy
- CzechiaABELCET LIPID COMPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- CzechiaABELCET LIPID COMPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- BelgiumAbelcet Lipid Complex 5 mg/mlTeva Pharma Belgium
- SwitzerlandAmbisome
- SwitzerlandAmbisome
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8e5959ba-d47f-4410-bea3-009edc4538cd GET /v1/drugs/8e5959ba-d47f-4410-bea3-009edc4538cd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, dispersjon",
"source": "fest",
"status": "A",
"atc_name": "Amfotericin B",
"merkevare_id": "ID_BBCE2FCE-B87E-4E3D-9E19-4E32E91974E0",
"name_form_strength": "Amphotericin B liposomal Tillomed pulv til kons til inf væske, disp 50 mg",
"prescription_group": "C"
}See everything about amphotericin b.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.